FDA issues guidance to increase supply of infant formula
The agency has issued a guidance document to help increase the supply of infant formula in the U.S. The FDA intends to temporarily exercise enforcement discretion with respect to certain requirements for infant formulas that may not comply with certain statutory and regulatory requirements and is seeking information from manufacturers regarding the safety and nutritional adequacy of their products. This guidance document is intended to:
The FDA reports that this guidance document will remain in effect until November 14, 2022, and then they will evaluate whether an extension is necessary. The FDA says they will give public notice when the period of enforcement discretion ends.